401 related articles for article (PubMed ID: 27017166)
1. Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.
Dekker AM; Wiggers JK; Coelen RJ; van Golen RF; Besselink MG; Busch OR; Verheij J; Hollmann MW; van Gulik TM
HPB (Oxford); 2016 Mar; 18(3):262-70. PubMed ID: 27017166
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
[TBL] [Abstract][Full Text] [Related]
3. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
[TBL] [Abstract][Full Text] [Related]
4. Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma.
Coelen RJ; Wiggers JK; Nio CY; Besselink MG; Busch OR; Gouma DJ; van Gulik TM
HPB (Oxford); 2015 Jun; 17(6):520-8. PubMed ID: 25726722
[TBL] [Abstract][Full Text] [Related]
5. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection.
Groot Koerkamp B; Wiggers JK; Allen PJ; Besselink MG; Blumgart LH; Busch OR; Coelen RJ; D'Angelica MI; DeMatteo RP; Gouma DJ; Kingham TP; Jarnagin WR; van Gulik TM
J Am Coll Surg; 2015 Dec; 221(6):1041-9. PubMed ID: 26454735
[TBL] [Abstract][Full Text] [Related]
6. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
[TBL] [Abstract][Full Text] [Related]
7. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors.
Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA
Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378
[TBL] [Abstract][Full Text] [Related]
8. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
Cannon RM; Brock G; Buell JF
HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
[TBL] [Abstract][Full Text] [Related]
9. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
[TBL] [Abstract][Full Text] [Related]
10. Impact of intraoperative blood transfusion on short and long term outcomes after curative hepatectomy for intrahepatic cholangiocarcinoma: a propensity score matching analysis by the AFC-IHCC study group.
Gómez-Gavara C; Doussot A; Lim C; Salloum C; Lahat E; Fuks D; Farges O; Regimbeau JM; Azoulay D
HPB (Oxford); 2017 May; 19(5):411-420. PubMed ID: 28122668
[TBL] [Abstract][Full Text] [Related]
11. External biliary drainage following major liver resection for perihilar cholangiocarcinoma: impact on development of liver failure and biliary leakage.
Olthof PB; Coelen RJ; Wiggers JK; Besselink MG; Busch OR; van Gulik TM
HPB (Oxford); 2016 Apr; 18(4):348-53. PubMed ID: 27037204
[TBL] [Abstract][Full Text] [Related]
12. Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma.
Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
Surgery; 2017 Feb; 161(2):394-404. PubMed ID: 27712872
[TBL] [Abstract][Full Text] [Related]
13. Curative-intent Surgery for Perihilar Cholangiocarcinoma with and without Portal Vein Resection - A Comparative Analysis of Early and Late Outcomes.
Dumitraşcu T; Stroescu C; Braşoveanu V; Herlea V; Ionescu M; Popescu I
Chirurgia (Bucur); 2017; 112(3):308-319. PubMed ID: 28675366
[TBL] [Abstract][Full Text] [Related]
14. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
[TBL] [Abstract][Full Text] [Related]
15. Value of E-PASS models for predicting postoperative morbidity and mortality in resection of perihilar cholangiocarcinoma and gallbladder carcinoma.
Haga Y; Miyamoto A; Wada Y; Takami Y; Takeuchi H
HPB (Oxford); 2016 Mar; 18(3):271-8. PubMed ID: 27017167
[TBL] [Abstract][Full Text] [Related]
16. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic blood transfusion does not affect outcome after curative resection for advanced cholangiocarcinoma.
Müller SA; Mehrabi A; Rahbari NN; Warschkow R; Elbers H; Leowardi C; Fonouni H; Tarantino I; Schemmer P; Schmied BM; Büchler MW
Ann Surg Oncol; 2014 Jan; 21(1):155-64. PubMed ID: 23982253
[TBL] [Abstract][Full Text] [Related]
18. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma.
Chauhan A; House MG; Pitt HA; Nakeeb A; Howard TJ; Zyromski NJ; Schmidt CM; Ball CG; Lillemoe KD
HPB (Oxford); 2011 Feb; 13(2):139-47. PubMed ID: 21241432
[TBL] [Abstract][Full Text] [Related]
19. Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases.
Buettner S; van Vugt JLA; Gaspersz MP; Coelen RJS; Roos E; Labeur TA; Margonis GA; Ethun CG; Maithel SK; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick BA; Weber SM; Salem A; Martin RCG; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; IJzermans JNM; van Gulik TM; Pawlik TM; Groot Koerkamp B
HPB (Oxford); 2017 Aug; 19(8):735-740. PubMed ID: 28549744
[TBL] [Abstract][Full Text] [Related]
20. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
